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Carbon Dioxide Laser Treatment Using Methylene Blue–Assisted Sinus Tract Identification in
Hidradenitis SuppurativaAQ : 1
Keratinocytes and remnant of keratinocytes in
nodules, abscesses, and sinus tracts are radically
removed in surgical treatment of hidradenitis
suppurativa.1 WeAQ : 2 are now using methylene blue in
carbon dioxide laser surgery for patients with
moderate to severe hidradenitis lesions
(Hurley stage II-III). Methylene blue stains active
inflammatory nodules and sinus tracts. WeAQ : 3 use
a modified methylene blue staining technique by the
addition of 2% gel of methylcellulose
polymers to the dye. The resulting blue gel is
easier to handle than a liquid, and is injected or
probed into sinus tracts with either a syringe or
a cotton swab, resulting in limited dye spillage and
a clean operating field. Major tracts are normally
easy to probe without staining. However, tracts
with hidden orifices and minor branches of epi-
thelialized tracts with diameters too small
diameter to probe can be revealed using methylene
blue.½F1 Figure 1 shows instillation procedure in
a sinus tract and uptake of methylene blue gel in
lesional skin tissue.
Discussion
Several surgical treatment methods for hidradenitis
exist, hereunder, deroofing, excision, carbon dioxide
laser vaporization, and electrosurgery. Leaving epi-
thelialized tissue untreated may be one cause of
recurrent disease. Communicating tracts must be
found and explored intraoperatively for curative
excision or deroofing. The common method of
exploring sinus tracts is using a blunt probe. Electro-
surgery and carbon dioxide laser deroofing is often
combinedwith probing.2,3 Anothermethod to identify
sinus tracts is to use dye intraoperatively.
Methylene blue is a vital stain taken up by actively
absorbing tissues, among them stratified epithe-
lium. It is commonly used in head, neck, and
Figure 1. (A) A clear blue gel made frommethylthionine hydrochloride (methylene blue) 10 mg/mL and methylcellulose gel
2% (Methocel; OmniVision, Germany) mixed in a 1:20 equation can be probed or instilled easily into sinus tracts because of
its firm viscous consistency. Lesion located in the inguinal crease. The white discoloration and scarring is a result of
previous surgery. (B) After first pass carbon dioxide laser treatment, dye is taken up in an active nodule, whereas the
surrounding tissue is not stained. (C) After second pass treatment, apically from the first nodule, a small dyed nodule
appeared, connected by a small tract that could not be found by probingAQ : 6 .
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parathyroid surgery, for sentinel lymph node
detection, testing of the integrity of gastrointestinal
anastomosis as well as in fistuli and sinus detection
in bladder, bowel, anal, and pilonidal sinus surgery.
When comparing primary open, primary midline
closed, and marsupialization surgery of pilonidal
sinus disease, methylene blue was found to be the
most potent factor, leading to the largest reduction
in recurrence rate.4 Use of methylene blue is recently
described in wide excision surgery of hidradenitis,
but to our knowledge, there are no reports of
methylene blue use in hidradenitis laser surgery.5
Since 1997, we have used scanner-assisted carbon
dioxide laser with recurrent symptomatic HSAQ : 4
lesions with the technique of carbon dioxide laser
vaporization of nodules and sinus tracts. We con-
sider methylene blue to be a tissue-saving adjuvant,
as the outlining of affected structures warrants less
radical vaporization of tissue in affected areas. For
the patient, a smaller postoperative wound results
in faster healing, less scarring, and reduced risk of
skin contractures.
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